1-4 of 4
Georgine E. de Greef, MD PhD
Close
Sort by
Journal Articles

Trends in Incidence, Primary Treatment and Survival of Chronic Myelomonocytic Leukemia: A Nationwide Population-Based Study Among 1,359 Patients Diagnosed in the Netherlands from 1989 to 2012

Avinash G Dinmohamed, MSc, BASc, Mirian Brink, PhD, Otto Visser, MD PhD, Pieter Sonneveld, MDPhD, Arjan A van de Loosdrecht, MD PhD, Mojca Jongen-Lavrencic, MD PhD, Georgine E. de Greef, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4645.
https://doi.org/10.1182/blood.V124.21.4645.4645
Published: 2014
Journal Articles

Lymphocyte and Hematopoietic Stem and Progenitor Cell (HSPC) Subsets Mobilized By Either Plerixafor or G-GCSF: A Retrospective Comparison of Grafts Harvested in Healthy Allogeneic Stem Cell Donors

Georgine E. De Greef, MD PhD, Eric Braakman, PhD, Wendimagegn G Alemayehu, PhD, Larissa De Graaf, Peter van Geel, Meriam Grootes, Carla Engelman, Eefke Petersen, MDPhD, Otto Visser, MDhD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Jan J. Cornelissen, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2451.
https://doi.org/10.1182/blood.V124.21.2451.2451
Published: 2014
Journal Articles

Validation Of a Multi-Diagnostic Approach Including Flow Cytometry To Identify Specific Risk Categories Within Low and Intermediate-1 Risk Myelodysplastic Syndromes Within a Prospective Clinical Trial: A Study On Behalf Of The HOVON89 Study Group

Eline M.P. Cremers, MD, Theresia M. Westers, PhD, Canan Alhan, MD, Claudia Cali, Heleen A. Visser-Wisselaar, PhD, Dana A Chitu, PhD, Marian J.P.L. Stevens-Kroef, PhD, Pedro Silva Coelho, MD, Edo Vellenga, MD, PhD, Saskia K. Klein, MD PhD, Pierre W. Wijermans, MD, PhD, Georgine E. de Greef, MD, PhD, Martijn R. Schaafsma, MD, PhD, M Marwijk Kooy, MD, PhD, Petra Muus, MD, PhD, Gert J. Ossenkoppele, MD PhD, Joop H. Jansen, PhD, Arjan A. van de Loosdrecht, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1521.
https://doi.org/10.1182/blood.V122.21.1521.1521
Published: 2013
Journal Articles

The Mobilisation of Peripheral Blood Stemcells in Patients with High Risk or Relapsed Non-Hodgkin Lymphoma Does Not Lead to the Presence of Detectable Tumour Cells in the Stem Cell Harvest.

Georgine E. de Greef, MD PhD, Annemiek Broyl, MD, Jaco Kraan
Journal: Blood
Blood (2004) 104 (11): 2873.
https://doi.org/10.1182/blood.V104.11.2873.2873
Published: 2004